CIK 0001844280
THRN Thorne Healthtech, Inc.
Insider trading from SEC Form 4. Last filing Oct 18, 2023.
In brief
Thorne Healthtech, Inc. (THRN) has 24 SEC Form 4 filings on file from 9 insiders, the latest filed on Oct 18, 2023. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Thorne Healthtech, Inc., scored.
Transactions
The newest 50 of 51 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 16, 2023 | Sarah M Kauss director | DDisposition to issuer Common Stock | -105,874 | - | - | 0 | Oct 18, 2023 |
| Apr 4, 2023 | William C. McCamy President | FTax withholding Common Stock | -7,571 | $4.72 | $36k | 389,804 | Oct 18, 2023 |
| Oct 16, 2023 | William C. McCamy President | DDisposition to issuer Common Stock | -589,804 | - | - | 0 | Oct 18, 2023 |
| Oct 16, 2023 | Riccardo Braglia director | DDisposition to issuer Common Stockindirect: See Footnote | -5,424,550 | - | - | 0 | Oct 18, 2023 |
| Mar 24, 2023 | Thomas P. McKenna Chief Operating Officer | FTax withholding Common Stock | -11,257 | $4.70 | $53k | 795,740 | Oct 18, 2023 |
| Apr 4, 2023 | Saloni S. Varma Chief Financial Officer | FTax withholding Common Stock | -3,454 | $4.72 | $16k | 81,643 | Oct 18, 2023 |
| Apr 4, 2023 | Paul F Jacobson Chief Executive Officer | FTax withholding Common Stock | -45,338 | $4.72 | $214k | 1,825,966 | Oct 18, 2023 |
| Mar 24, 2023 | Paul F Jacobson Chief Executive Officer | FTax withholding Common Stock | -59,907 | $4.70 | $282k | 1,871,304 | Oct 18, 2023 |
| Oct 16, 2023 | Thomas P. McKenna Chief Operating Officer | DDisposition to issuer Common Stock | -1,172,227 | - | - | 0 | Oct 18, 2023 |
| Oct 16, 2023 | Saloni S. Varma Chief Financial Officer | DDisposition to issuer Common Stock | -581,643 | - | - | 0 | Oct 18, 2023 |
| Oct 16, 2023 | Paul F Jacobson Chief Executive Officer | DDisposition to issuer Common Stock | -2,105,589 | - | - | 0 | Oct 18, 2023 |
| Oct 16, 2023 | William C. McCamy President | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -156,640 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | Riccardo Braglia director | DDisposition to issuer Warrant (Right to buy)derivativeindirect: See Footnote | -453,455 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | Thomas P. McKenna Chief Operating Officer | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -89,000 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | Paul F Jacobson Chief Executive Officer | DDisposition to issuer Common Stockindirect: See Footnote | -220,377 | - | - | 0 | Oct 18, 2023 |
| Oct 16, 2023 | William C. McCamy President | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -17,355 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | Paul F Jacobson Chief Executive Officer | DDisposition to issuer Common Stockindirect: See Footnote | -1,602,445 | - | - | 0 | Oct 18, 2023 |
| Oct 16, 2023 | Thomas P. McKenna Chief Operating Officer | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -178,000 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | William C. McCamy President | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -31,150 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | Paul F Jacobson Chief Executive Officer | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -208,100 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | Thomas P. McKenna Chief Operating Officer | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -186,900 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | William C. McCamy President | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -39,605 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | Thomas P. McKenna Chief Operating Officer | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -639,910 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | Paul F Jacobson Chief Executive Officer | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -244,750 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | Paul F Jacobson Chief Executive Officer | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -244,750 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | William C. McCamy President | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -89,000 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | Paul F Jacobson Chief Executive Officer | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -1,279,375 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | William C. McCamy President | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -178,000 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | Paul F Jacobson Chief Executive Officer | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -36,045 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | William C. McCamy President | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -186,900 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | Paul F Jacobson Chief Executive Officer | DDisposition to issuer Warrant (Right to buy)derivativeindirect: See Footnote | -2,532,050 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | William C. McCamy President | DDisposition to issuer Employee Stock Option (Right to buy)derivative | -639,910 | $0.00 | $0 | 0 | Oct 18, 2023 |
| Oct 16, 2023 | Mitsui & Co Ltd owner | UTender of shares Common Stock | -15,674,235 | - | - | 0 | Oct 17, 2023 |
| Oct 12, 2023 | Kirin Holdings Company, Ltd /FI owner | UTender of shares Common Stock | -15,674,235 | $10.20 | $160M | 0 | Oct 17, 2023 |
| Oct 16, 2023 | Mitsui & Co Ltd owner | JOther Class A Common Stock Warrant (Right to buy)derivative | -56,515 | - | - | 0 | Oct 17, 2023 |
| Oct 12, 2023 | Kirin Holdings Company, Ltd /FI owner | XIn-the-money exercise Warrants (right to buy)derivative | -56,515 | - | - | 0 | Oct 17, 2023 |
| Apr 4, 2023 | Paul F Jacobson Chief Executive Officer | FTax withholding Common Stock | -40,556 | $4.72 | $191k | 1,838,036 | Apr 6, 2023 |
| Apr 4, 2023 | Sarah M Kauss director | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 105,874 | Apr 6, 2023 |
| Apr 4, 2023 | William C. McCamy President | FTax withholding Common Stock | -7,609 | $4.72 | $36k | 389,766 | Apr 6, 2023 |
| Apr 4, 2023 | Thomas P. McKenna Chief Operating Officer | FTax withholding Common Stock | -23,513 | $4.72 | $111k | 772,044 | Apr 6, 2023 |
| Apr 4, 2023 | Saloni S. Varma Chief Financial Officer | FTax withholding Common Stock | -6,430 | $4.72 | $30k | 78,667 | Apr 6, 2023 |
| Apr 4, 2023 | Paul F Jacobson Chief Executive Officer | AGrant or award Common Stock | +500,000 | $0.00 | $0 | 2,338,036 | Apr 6, 2023 |
| Apr 4, 2023 | William C. McCamy President | AGrant or award Common Stock | +200,000 | $0.00 | $0 | 589,766 | Apr 6, 2023 |
| Apr 4, 2023 | Thomas P. McKenna Chief Operating Officer | AGrant or award Common Stock | +400,000 | $0.00 | $0 | 1,172,044 | Apr 6, 2023 |
| Apr 4, 2023 | Saloni S. Varma Chief Financial Officer | AGrant or award Common Stock | +500,000 | $0.00 | $0 | 578,667 | Apr 6, 2023 |
| Mar 24, 2023 | Paul F Jacobson Chief Executive Officer | FTax withholding Common Stock | -52,619 | $4.70 | $247k | 1,878,592 | Mar 28, 2023 |
| Mar 24, 2023 | Thomas P. McKenna Chief Operating Officer | FTax withholding Common Stock | -11,440 | $4.70 | $54k | 795,557 | Mar 28, 2023 |
| Dec 1, 2022 | Bryan K. Conley Chief Financial Officer | FTax withholding Common Stock | -7,838 | $4.89 | $38k | 222,162 | Dec 5, 2022 |
| Dec 1, 2022 | Paul F Jacobson Chief Executive Officer | FTax withholding Common Stock | -45,338 | $4.89 | $222k | 1,931,211 | Dec 5, 2022 |
| Dec 1, 2022 | William C. McCamy President | FTax withholding Common Stock | -12,175 | $4.89 | $60k | 397,375 | Dec 5, 2022 |
Insiders
Everyone who has filed a Form 4 here.
- Riccardo Bragliadirector
- Bryan K. ConleyChief Financial Officer
- Paul F JacobsonChief Executive Officer
- Sarah M Kaussdirector
- Kirin Holdings Company, Ltd /FIowner
- Mitsui & Co Ltdowner
- William C. McCamyPresident
- Thomas P. McKennaChief Operating Officer
- Saloni S. VarmaChief Financial Officer
Questions about THRN
Answered from the filings on this page, as of the latest one.
Are insiders buying THRN?
No. In the last 90 days no insider at Thorne Healthtech, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade THRN on the open market?
No open-market trade has been scored at Thorne Healthtech, Inc.. The latest Form 4 on file was filed on Oct 18, 2023 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Thorne Healthtech, Inc.?
9 people have filed a Form 4 at Thorne Healthtech, Inc., among them Riccardo Braglia (director), Bryan K. Conley (Chief Financial Officer), Paul F Jacobson (Chief Executive Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.